Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07604974 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Assess the Safety, Tolerability and Efficacy of ION775

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study sites: 16 to 17v5
  2. Trial sites expanded: 8 → 16 locationsv4
  3. Start date changed from estimate of May 2026 to May 12, 2026v3
  4. Trial sites expanded: 3 → 8 locationsv2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The main objective of this study is to evaluate the effect of ION775 on fasting triglyceride (TG) levels in participants with hypertriglyceridemia (HTG) and severe hypertriglyceridemia (sHTG).
Trial Details
NCT Number NCT07604974
Lead Sponsor Ionis Pharmaceuticals, Inc.
Conditions Hypertriglyceridemia, Severe Hypertriglyceridemia
Enrollment 72 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov